138 related articles for article (PubMed ID: 26051726)
1. The influence of joint application of arsenic trioxide and daunorubicin on primary acute promyelocytic leukaemia cells and apoptosis and blood coagulation of cell strain.
Zhang X; Qin N; Chen X; Guo S
Pak J Pharm Sci; 2015 May; 28(3 Suppl):1075-8. PubMed ID: 26051726
[TBL] [Abstract][Full Text] [Related]
2. [Effect of arsenic trioxide and daunorubicin on procoagulant activity of acute promyelocytic leukemia cells].
Shi JL; Li JM; Hou JX; Cao FL; Liu SC; Zhou J; Gao CY; Wang J; Tan XY; Li JN; Liu Y; Liu Y; Ma RS; Yang X
Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(16):1095-9. PubMed ID: 22781766
[TBL] [Abstract][Full Text] [Related]
3. [Effects of all-trans retinoic acid, arsenic trioxide and daunorubicin on tissue factor expression in NB4 cells].
Guo W; Zhu J; Wang H
Zhonghua Xue Ye Xue Za Zhi; 1999 Sep; 20(9):453-5. PubMed ID: 11721405
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylserine exposure and procoagulant activity in acute promyelocytic leukemia.
Zhou J; Shi J; Hou J; Cao F; Zhang Y; Rasmussen JT; Heegaard CW; Gilbert GE
J Thromb Haemost; 2010 Apr; 8(4):773-82. PubMed ID: 20102487
[TBL] [Abstract][Full Text] [Related]
5. [Effects of arsenic trioxide or retinoic acid on mRNA and protein expression of tissue factor and thrombomodulin and procoagulant activity in NB4 cells].
Zhang XH; Hu Y; Hong M; Xia LH; Guo T; Shen GX; Wei WN; Song SJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):391-5. PubMed ID: 17493354
[TBL] [Abstract][Full Text] [Related]
6. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
[TBL] [Abstract][Full Text] [Related]
7. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells.
Guo W; Wang H; Zhao W; Zhu J; Ju B; Wang X
Chin Med J (Engl); 2001 Jan; 114(1):30-4. PubMed ID: 11779431
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis induction by (+)alpha-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells.
Freitas RA; Silva dos Santos GA; Gimenes Teixeira HL; Scheucher PS; Lucena-Araujo AR; Lima AS; Abreu e Lima RS; Garcia AB; Jordão AA; Falcão RP; Vannucchi H; Rego EM
Leuk Res; 2009 Jul; 33(7):958-63. PubMed ID: 19013639
[TBL] [Abstract][Full Text] [Related]
9. Effect of the combination of ATRA, ATO and DNR on CD11b expression in NB4 cells.
Zhang W; Wei F; Zhang X; Li D
Leuk Res; 2008 Oct; 32(10):1625-6. PubMed ID: 18282598
[No Abstract] [Full Text] [Related]
10. [Effect of daunorubicin and cytarabine on cell line NB4].
Luo ZG; Zhong L; Chen FY; Wang HR; Ouyang RR
Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):247-9. PubMed ID: 17877202
[TBL] [Abstract][Full Text] [Related]
11. Effect of ATRA and ATO on the expression of tissue factor in NB4 acute promyelocytic leukemia cells and regulatory function of the inflammatory cytokines TNF and IL-1β.
Dunoyer-Geindre S; Rivier-Cordey AS; Tsopra O; Lecompte T; Kruithof EKO
Ann Hematol; 2017 Jun; 96(6):905-917. PubMed ID: 28343272
[TBL] [Abstract][Full Text] [Related]
12. Aquaporin 9, a promising predictor for the cytocidal effects of arsenic trioxide in acute promyelocytic leukemia cell lines and primary blasts.
Iriyama N; Yuan B; Yoshino Y; Hatta Y; Horikoshi A; Aizawa S; Takeuchi J; Toyoda H
Oncol Rep; 2013 Jun; 29(6):2362-8. PubMed ID: 23563754
[TBL] [Abstract][Full Text] [Related]
13. Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents.
Zhu J; Guo WM; Yao YY; Zhao WL; Pan L; Cai X; Ju B; Sun GL; Wang HL; Chen SJ; Chen GQ; Caen J; Chen Z; Wang ZY
Leukemia; 1999 Jul; 13(7):1062-70. PubMed ID: 10400422
[TBL] [Abstract][Full Text] [Related]
14. [Influence of arsenic trioxide and daunorubicin on the expression of annexin II and fibrinolytic activity in NB4 cells].
Liu YH; Wang ZY; Dai L; Shen WH; Cen JN; Zhang W; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2010 Dec; 31(12):813-6. PubMed ID: 21223737
[TBL] [Abstract][Full Text] [Related]
15. [Apoptosis of NB4 cells induced by Tanshinone II A combined with arsenic trioxide].
Zhang G; Yang YM; Meng WT; Zhou J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 41(1):57-61. PubMed ID: 20369471
[TBL] [Abstract][Full Text] [Related]
16. Gefitinib enhances arsenic trioxide (AS2O3)-induced differentiation of acute promyelocytic leukemia cell line.
Noh EK; Kim H; Park MJ; Baek JH; Park JH; Cha SJ; Won JH; Min YJ
Leuk Res; 2010 Nov; 34(11):1501-5. PubMed ID: 20226526
[TBL] [Abstract][Full Text] [Related]
17. Redistribution of cell cycle by arsenic trioxide is associated with demethylation and expression changes of cell cycle related genes in acute promyelocytic leukemia cell line (NB4).
Hassani S; Khaleghian A; Ahmadian S; Alizadeh S; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
Ann Hematol; 2018 Jan; 97(1):83-93. PubMed ID: 29159499
[TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: clinicopathological and molecular features of a pilot study.
Kwong YL; Au WY; Chim CS; Pang A; Suen C; Liang R
Am J Hematol; 2001 Apr; 66(4):274-9. PubMed ID: 11279639
[TBL] [Abstract][Full Text] [Related]
19. Chloroquine aggravates the arsenic trioxide (As2O3)-induced apoptosis of acute promyelocytic leukemia NB4 cells via inhibiting lysosomal degradation in vitro.
Liu DM; Zhang XD; Yang L
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6412-6421. PubMed ID: 30338810
[TBL] [Abstract][Full Text] [Related]
20. High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro.
Noguera NI; Pelosi E; Angelini DF; Piredda ML; Guerrera G; Piras E; Battistini L; Massai L; Berardi A; Catalano G; Cicconi L; Castelli G; D'Angiò A; Pasquini L; Graziani G; Fioritoni G; Voso MT; Mastrangelo D; Testa U; Lo-Coco F
Oncotarget; 2017 May; 8(20):32550-32565. PubMed ID: 28427227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
